Abstract
During a crisis, the messaging platform WhatsApp allows crisis-related information to be disseminated quickly. Although case studies have documented how WhatsApp has shaped crisis outcomes in both beneficial and harmful ways, little is known about: (i) how crisis-related content is spread; (ii) characteristics of users based on usage patterns; or (iii) how usage patterns link to well-being. During the coronavirus disease 2019 (COVID-19) crisis, this study used the experience sampling method to track the daily WhatsApp usage of 151 adults throughout one week (capturing a total of 924 days of crisis-related communication). Each day, participants reported the extent to which they had received, forwarded, or discussed COVID-19-related content. During the week-long monitoring, most participants (94.7%) reported at least one COVID-19 related use of WhatsApp. Those who engaged with more COVID-19 content in personal chats were more likely to report having COVID-19 thoughts throughout the day. We further observed that around 1 in 10 individuals (14%) were chronic users who received and shared forwarded COVID-19 messages at a high volume; this group may represent everyday ‘super spreaders’ of crisis-related content. Together, these findings provide an empirical base for policy makers to manage risk communication during large-scale crises.
Highlights
WhatsApp is used for information-sharing during crises.
In the COVID-19 crisis, nearly all participants used WhatsApp to receive or send crisis-related content during one week of monitoring.
Users who engaged with more COVID-19 content reported higher levels of COVID-19 thoughts throughout the day.
1 in 10 participants shared a high number of forwarded COVID-19 messages, and may represent ‘super-spreaders’ of crisis-related information.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04367363
Funding Statement
This research was funded by a grant awarded to JCJL from the JY Pillay Global Asia Programme (Grant number: IG20-SG002). The first authors (EYQT) involvement was funded by a centre grant awarded to the Centre for Sleep and Cognition.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Yale-NUS College Ethics Review Committee
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available on request from the corresponding author (JCJL). The data are not publicly available due to IRB restrictions.
